Arch Biopartners (TSXV:ARCH) Forward Dividend Yield % : 0.00% (As of May. 26, 2024)

View and export this data going back to 2000. Start your Free Trial

What is Arch Biopartners Forward Dividend Yield %?

As of today (2024-05-26), the Forward Annual Dividend Yield of Arch Biopartners is 0.00%.

As of today (2024-05-26), the Trailing Annual Dividend Yield of Arch Biopartners is 0.00%.

TSXV:ARCH's Forward Dividend Yield % is not ranked ^*
in the Biotechnology industry.
Industry Median: 1.6
* Ranked among companies with meaningful Forward Dividend Yield % only.

Arch Biopartners's Dividends per Share for the three months ended in Dec. 2023 was C$0.00.

During the past 13 years, the highest 3-Year average Dividends Per Share Growth Rate of Arch Biopartners was -0.60% per year. The lowest was -0.60% per year. And the median was -0.60% per year.

The growth rate is calculated with least square regression.

For more information regarding to dividend, please check our Dividend Page.

Competitive Comparison of Arch Biopartners's Forward Dividend Yield %

For the Biotechnology subindustry, Arch Biopartners's Forward Dividend Yield %, along with its competitors' market caps and Forward Dividend Yield % data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Arch Biopartners's Forward Dividend Yield % Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Arch Biopartners's Forward Dividend Yield % distribution charts can be found below:

* The bar in red indicates where Arch Biopartners's Forward Dividend Yield % falls into.

Arch Biopartners Forward Dividend Yield % Calculation

Dividend Yield measures how much a company pays out in dividends each year relative to its share price.

Arch Biopartners (TSXV:ARCH) Forward Dividend Yield % Explanation

Over the long term, the return from dividends has been a significant contributor to the total returns produced by equity securities. Studies by Elroy Dimson, Paul Marsh, and Mike Staunton of Princeton University (2002) found that a market-oriented portfolio, which included reinvested dividends, would have generated nearly 85 times the wealth generated by the same portfolio relying solely on capital gains.

Dividends may also qualify a lower tax rate for investors.

In dividends investing, Payout Ratio and Dividend Growth Rate are the two most important variables for consideration. A lower payout ratio may indicate that the company has more room to increase its dividends.

You can find the stocks that owned most by Gurus here. Or you can check out Warren Buffett's highest dividend stocks here.

Arch Biopartners Forward Dividend Yield % Related Terms

Thank you for viewing the detailed overview of Arch Biopartners's Forward Dividend Yield % provided by GuruFocus.com. Please click on the following links to see related term pages.

Arch Biopartners (TSXV:ARCH) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Arch Biopartners Inc (TSXV:ARCH) » Definitions » Forward Dividend Yield %

Comparable Companies

Traded in Other Exchanges

N/A

Address

545 King Street West, Toronto, ON, CAN, M5V 1M1

Website

https://www.archbiopartners.com

Arch Biopartners Inc is a clinical stage company developing technologies with the potential to make medical or commercial impacts. The company is developing a drug platform Metablok to produce drug candidates to inhibit organ inflammation caused via the DPEP-1 pathway. It's under development portfolio is AB569, a potential new treatment for antibiotic resistant bacterial infections in the lungs or wounds; and, Borg peptide coatings that increase corrosion resistance and decrease bacterial biofilm on various medical grade metals and plastics.